Citation: Gu Yiyu, Lü Xiaoqing, Ma Xiaodong, Zhang Haojian, Ji Yuanyuan, Ding Wanjing, Shen Li. Design, Synthesis and Biological Evaluation of Novel (Quinolinyl-3-pyridinyl)benzenesulfonamide-Based Hydroxamic Acids as PI3K and HDAC Dual Targeting Inhibitors[J]. Chinese Journal of Organic Chemistry, ;2020, 40(1): 95-107. doi: 10.6023/cjoc201908021 shu

Design, Synthesis and Biological Evaluation of Novel (Quinolinyl-3-pyridinyl)benzenesulfonamide-Based Hydroxamic Acids as PI3K and HDAC Dual Targeting Inhibitors

a.
Ocean College, Zhejiang University, Zhoushan, Zhejiang 316021
b.
College of Medicine, Jiaxing University, Jiaxing, Zhejiang 314001
c.
School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012

Corresponding author: Shen Li, shenli@zju.edu.cn
Received Date: 13 August 2019
Revised Date: 5 September 2019
Available Online: 18 January 2019
Fund Project: the Foundation for the Science and Technology Project of Zhoushan City 2018C81035the National Natural Science Foundation for Young Scientists of China 81402845Project supported by the National Natural Science Foundation for Young Scientists of China (No. 81402845) and the Foundation for the Science and Technology Project of Zhoushan City (No. 2018C81035)

Figures(4)

Polypharmacology has emerged as a promising approach to drug discovery, especially antitumor drug. This study reports the design, synthesis, and biological evaluation of novel phosphatidylinositol 3-kinases (PI3Ks) and histone deacetylases (HDACs) dual inhibitors on the basis of GSK2126458 under clinical evaluation and vorinostat approved. Among these hybrid molecules, GYB-4 and GYB-5 possessed potent inhibition against both PI3Kα (1.0 and 1.3 nmol/L, respectively) and HDAC1 (4.2 and 4.8 nmol/L, respectively). Antiproliferative assays with HCT116, PC3 and A2780 cell lines subsequently were performed. The structure-activity relationship study will guide to optimization of dual PI3K and HDAC inhibitors.
- phosphatidylinositol 3-kinases (PI3K),
- histone deacetylases (HDAC),
- dual targeting inhibitor,
- bioactivity
1. [1]
  Porta, C.; Paglino, C.; Mosca, A. Front Oncol. 2014, 4, 64.
2. [2]
  Pons-Tostivint, E.; Thibault, B.; Guillermet-Guibert, J. Trends Cancer 2017, 3, 454. doi: 10.1016/j.trecan.2017.04.002
3. [3]
  Nelson, C. M.; Chen, C. S. FEBS Lett. 2002, 514, 238. doi: 10.1016/S0014-5793(02)02370-0
4. [4]
  Okkenhaug, K.; Vanhaesebroeck, B. Nat. Rev. Immunol. 2003, 3, 317. doi: 10.1038/nri1056
5. [5]
  Cantley, L. C. Science 2002, 296, 1655. doi: 10.1126/science.296.5573.1655
6. [6]
  Ikenoue, T.; Kanai, F.; Hikiba, Y.; Obata, T.; Tanaka, Y.; Imamura, J.; Ohta, M.; Jazag, A.; Guleng, B.; Tateishi, K.; Asaoka, Y.; Matsumura, M.; Kawabe, T.; Omata, M. Cancer Res. 2005, 65, 4562. doi: 10.1158/0008-5472.CAN-04-4114
7. [7]
  Fruman, D. A.; Rommel, C. Nat. Rev. Drug Discovery 2014, 13, 140. doi: 10.1038/nrd4204
8. [8]
  West, A. C.; Johnstone, R. W. J. Clin. Invest. 2014, 124, 30. doi: 10.1172/JCI69738
9. [9]
  Polo, S. E.; Almouzni, G. Cancer Lett. 2005, 220, 1. doi: 10.1016/j.canlet.2004.08.024
10. [10]
  Vidanes, G. M.; Bonilla, C. Y.; Toczyski, D. P. Cell 2005, 121, 973. doi: 10.1016/j.cell.2005.06.013
11. [11]
  Friedrich, M.; Gerbeth, L.; Gerling, M.; Rosenthal, R.; Steiger, K.; Weidinger, C.; Keye, J.; Wu, H.; Schmidt, F.; Weichert, W.; Siegmund, B.; Glauben, R. Mucosal Immunol. 2019, 12, 656. doi: 10.1038/s41385-019-0135-7
12. [12]
  Yang, J.; Jin, X.; Yan, Y.-Q.; Shao, Y.-J.; Pan, Y.-Q.; Roberts, L. R.; Zhang, J.; Huang, H.-J.; Jiang, J.-T. Sci. Rep. 2017, 7, 43864. doi: 10.1038/srep43864
13. [13]
  Zhou, W.-Q.; Feng, X.-Y.; Han, H.; Guo, S.-C.; Wang, G.-D. Sci. Rep. 2016, 6, 28004. doi: 10.1038/srep28004
14. [14]
  Marks, P. A.; Breslow, R. Nat. Biotechnol. 2007, 25, 84. doi: 10.1038/nbt1272
15. [15]
  McKinsey, T. A. Annu. Rev. Pharmacol. Toxicol. 2012, 52, 303. doi: 10.1146/annurev-pharmtox-010611-134712
16. [16]
  Xing, S.-F.; Nie, F.; Xu, Q.; Deng, Y.-X.; Li, W.; Yang, Z.-W.; Zhao, X.-Y.; Zhu, P.; Wang, X.-R.; Gao, Y.; He, Z.-Y. Lab. Invest. 2015, 95, 1105. doi: 10.1038/labinvest.2015.97
17. [17]
  Grant, S.; Easley, C.; Kirkpatrick, P. Nat. Rev. Drug Discovery 2007, 6, 21. doi: 10.1038/nrd2227
18. [18]
  Bertino, E. M.; Otterson, G. A. Expert Opin. Investig. Drugs 2011, 20, 1151. doi: 10.1517/13543784.2011.594437
19. [19]
  Poole, R. M. Drugs 2014, 74, 1543. doi: 10.1007/s40265-014-0275-8
20. [20]
  Garnock-Jones, K. P. Drugs 2015, 75, 695. doi: 10.1007/s40265-015-0388-8
21. [21]
  Ning, Z.-Q.; Li, Z.-B.; Newman, M. J.; Shan, S.; Wang, X.-H.; Pan, D.-S.; Zhang, J.; Dong, M.; Du, X.; Lu, X.-P. Cancer Chemother. Pharmacol. 2012, 69, 901. doi: 10.1007/s00280-011-1766-x
22. [22]
  Nervi, C.; De Marinis, E.; Codacci-Pisanelli, G. Clin. Epigenet. 2015, 7, 127. doi: 10.1186/s13148-015-0157-2
23. [23]
  Ozaki, K.; Kosugi, M.; Baba, N.; Fujio, K.; Sakamoto, T.; Kimura, S.; Tanimura, S.; Kohno, M. Biochem. Biophys. Res. Commun. 2010, 391, 1610. doi: 10.1016/j.bbrc.2009.12.086
24. [24]
  Yoshioka, T.; Yogosawa, S.; Yamada, T.; Kitawaki, J.; Sakai, T. Gynecol. Oncol. 2013, 129, 425. doi: 10.1016/j.ygyno.2013.02.008
25. [25]
  Ellis, L.; Ku, S. Y.; Ramakrishnan, S.; Lasorsa, E.; Azabdaftari, G.; Godoy, A.; Pili, R. Oncotarget 2013, 4, 2225.
26. [26]
  Rahmani, M.; Aust, M. M.; Benson, E. C.; Wallace, L.; Friedberg, J.; Grant, S. Clin. Cancer Res. 2014, 20, 4849. doi: 10.1158/1078-0432.CCR-14-0034
27. [27]
  Anighoro, A.; Bajorath, J.; Rastelli, G. J. Med. Chem. 2014, 57, 7874. doi: 10.1021/jm5006463
28. [28]
  Peters, J. U. J. Med. Chem. 2013, 56, 8955. doi: 10.1021/jm400856t
29. [29]
  Gupta, A. K.; Arshad, S.; Poulter, N. R. Hypertension 2010, 55, 399. doi: 10.1161/HYPERTENSIONAHA.109.139816
30. [30]
  Knight, S. D.; Adams, N. D.; Burgess, J. L.; Chaudhari, A. M.; Darcy, M. G.; Donatelli, C. A.; Luengo, J. I.; Newlander, K. A.; Parrish, C. A.; Ridgers, L. H.; Sarpong, M. A.; Schmidt, S. J.; Van Aller, G. S.; Carson, J. D.; Diamond, M. A.; Elkins, P. A.; Gardiner, C. M.; Garver, E.; Gilbert, S. A.; Gontarek, R. R.; Jackson, J. R.; Kershner, K. L.; Luo, L.; Raha, K.; Sherk, C. S.; Sung, C. M.; Sutton, D.; Tummino, P. J.; Wegrzyn, R. J.; Auger, K. R.; Dhanak, D. ACS Med. Chem.Lett. 2010, 1, 39. doi: 10.1021/ml900028r
31. [31]
  Lv, X.-Q.; Ying, H.-Z.; Ma, X.-D.; Qiu, N.; Wu, P.; Yang, B.; Hu, Y.-Z., Eur. J. Med. Chem. 2015, 99, 36. doi: 10.1016/j.ejmech.2015.05.025
32. [32]
  De Simone, A.; La Pietra, V.; Betari, N.; Petragnani, N.; Conte, M.; Daniele, S.; Pietrobono, D.; Martini, C.; Petralla, S.; Casadei, R.; Davani, L.; Frabetti, F.; Russomanno, P.; Novellino, E.; Montanari, S.; Tumiatti, V.; Ballerini, P.; Sarno, F.; Nebbioso, A.; Altucci, L.; Monti, B.; Andrisano, V.; Milelli, A. ACS Med. Chem. Lett. 2019, 10, 469. doi: 10.1021/acsmedchemlett.8b00507
33. [33]
  Finnin, M. S.; Donigian, J. R.; Cohen, A.; Richon, V. M.; Rifkind, R. A.; Marks, P. A.; Breslow, R.; Pavletich, N. P. Nature 1999, 401, 188. doi: 10.1038/43710
34. [34]
  Morphy, R.; Rankovic, Z. J. Med. Chem. 2005, 48, 6523. doi: 10.1021/jm058225d
35. [35]
  Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457. doi: 10.1021/cr00039a007
36. [36]
  Andrianov, V.; Gailite, V.; Lola, D.; Loza, E.; Semenikhina, V.; Kalvinsh, I.; Finn, P.; Petersen, K. D.; Ritchie, J. W.; Khan, N.; Tumber, A.; Collins, L. S.; Vadlamudi, S. M.; Bjorkling, F.; Sehested, M. Eur. J. Med. Chem. 2009, 44, 1067. doi: 10.1016/j.ejmech.2008.06.020
37. [37]
  Lagger, G.; O'Carroll, D.; Rembold, M.; Khier, H.; Tischler, J.; Weitzer, G.; Schuettengruber, B.; Hauser, C.; Brunmeir, R.; Jenuwein, T.; Seiser, C. EMBO J. 2002, 21, 2672. doi: 10.1093/emboj/21.11.2672
38. [38]
  Raynaud, F. I.; Eccles, S. A.; Patel, S.; Alix, S.; Box, G.; Chuckowree, I.; Folkes, A.; Gowan, S.; De Haven Brandon, A.; Di Stefano, F.; Hayes, A.; Henley, A. T.; Lensun, L.; Pergl-Wilson, G.; Robson, A.; Saghir, N.; Zhyvoloup, A.; McDonald, E.; Sheldrake, P.; Shuttleworth, S.; Valenti, M.; Wan, N. C.; Clarke, P. A.; Workman, P. Mol. Cancer Ther. 2009, 8, 1725. doi: 10.1158/1535-7163.MCT-08-1200
39. [39]
  Botta, C. B.; Cabri, W.; Cini, E.; De Cesare, L.; Fattorusso, C.; Giannini, G.; Persico, M.; Petrella, A.; Rondinelli, F.; Rodriquez, M.; Russo, A.; Taddei, M. J. Med. Chem. 2011, 54, 2165. doi: 10.1021/jm101373a
40. [40]
  Crawford, T. D.; Vartanian, S.; CÖté, A.; Bellon, S.; Duplessis, M.; Flynn, E. M.; Hewitt, M.; Huang, H.-R.; Kiefer, J. R.; Murray, J.; Nasveschuk, C. G.; Pardo, E.; Romero, F. A.; Sandy, P.; Tang, Y.; Taylor, A. M.; Tsui, V.; Wang, J.; Wang, S.; Zawadzke, L.; Albrecht, B. K.; Magnuson, S. R.; Cochran, A. G.; Stokoe, D. Bioorg. Med. Chem. Lett. 2017, 27, 3534. doi: 10.1016/j.bmcl.2017.05.063
41. [41]
  Ding, H.-W.; Deng, C.-L.; Li, D.-D.; Liu, D.-D.; Chai, S.-M.; Wang, W.; Zhang, Y.; Chen, K.; Li, X.; Wang, J.; Song, S.-J.; Song, H.-R. Eur. J. Med. Chem. 2018, 146, 460. doi: 10.1016/j.ejmech.2018.01.081
42. [42]
  Zhang, J.-K.; Lv, X.-Q.; Ma, X.-D.; Hu, Y.-Z. Eur. J. Med. Chem. 2017, 127, 509. doi: 10.1016/j.ejmech.2017.01.016
43. [43]
  Zhang, K.-H.; Lai, F.-F.; Lin, S.-W.; Ji, M.; Zhang, J.-B.; Zhang, Y.; Jin, J.; Fu, R.; Wu, D.-Y.; Tian, H.; Xue, N.-N.; Sheng, L.; Zou, X.-W.; Li, Y.; Chen, X.-G.; Xu, H. J. Med. Chem. 2019.
44. [44]
  Yao, L.-B.; Mustafa, N.; Tan, E. C.; Poulsen, A.; Singh, P.; Duong-Thi, M.-D.; Lee, J. X. T.; Ramanujulu, P. M.; Chng, W. J.; Yen, J. J. Y.; Ohlson, S.; Dymock, B. W. J. Med. Chem. 2017, 60, 8336. doi: 10.1021/acs.jmedchem.7b00678
1. [1]
  Zhenxing Li , Yue Ding , Xinxin Tuo , Jinhong Hu , Taihong Zhang , Xiang Zhou , Liwei Liu , Song Yang . Structure-based drug repurposing targeting pathogenic virus superfamily 1 helicase: An integrated multi-computational screening and bioactivity identification strategy. Chinese Chemical Letters, 2025, 36(9): 110737-. doi: 10.1016/j.cclet.2024.110737
2. [2]
  Zimo Yang , Yan Tong , Yongbo Liu , Qianlong Liu , Zhihao Ni , Yuna He , Yu Rao . Developing selective PI3K degraders to modulate both kinase and non-kinase functions. Chinese Chemical Letters, 2024, 35(11): 109577-. doi: 10.1016/j.cclet.2024.109577
3. [3]
  Kun Zou , Yihang Xiao , Jinyu Yang , Mingxuan Wu . Facile semisynthesis of histone H3 enables nucleosome probes for investigation of histone H3K79 modifications. Chinese Chemical Letters, 2024, 35(10): 109497-. doi: 10.1016/j.cclet.2024.109497
4. [4]
  Xiongbo Song , Jinwen Xiao , Juan Wu , Li Sun , Long Chen . Decellularized amniotic membrane promotes the anti-inflammatory response of macrophages via PI3K/AKT/HIF-1α pathway. Chinese Chemical Letters, 2025, 36(1): 109844-. doi: 10.1016/j.cclet.2024.109844
5. [5]
  Jisheng Liu , Junli Chen , Xifeng Zhang , Yin Wu , Xin Qi , Jie Wang , Xiang Gao . Red blood cell membrane-coated FLT3 inhibitor nanoparticles to enhance FLT3-ITD acute myeloid leukemia treatment. Chinese Chemical Letters, 2024, 35(9): 109779-. doi: 10.1016/j.cclet.2024.109779
6. [6]
  Cheng-Zhe Gao , Hao-Ran Jia , Tian-Yu Wang , Xiao-Yu Zhu , Xiaofeng Han , Fu-Gen Wu . A dual drug-loaded tumor vasculature-targeting liposome for tumor vasculature disruption and hypoxia-enhanced chemotherapy. Chinese Chemical Letters, 2025, 36(1): 109840-. doi: 10.1016/j.cclet.2024.109840
7. [7]
  Haotian Shi , Yuchao Luo , Song Zhang , Meijun Zhao , Chaoyong Liu , Qing Pei , Helei Wang , Qiong Dai , Zhigang Xie , Bin Xu , Wenjing Tian . Dual-responsive nanogels with high drug loading for enhanced tumor targeting and treatment. Chinese Chemical Letters, 2025, 36(10): 110775-. doi: 10.1016/j.cclet.2024.110775
8. [8]
  Zhaoyong Kang , Shen Li , Yan Li , Jingfeng Song , Yangrui Peng , Yihua Chen . Small molecular inhibitors and degraders targeting STAT3 for cancer therapy: An updated review (from 2022 to 2024). Chinese Chemical Letters, 2025, 36(7): 110447-. doi: 10.1016/j.cclet.2024.110447
9. [9]
  Run Chai , Qiujie Wu , Yongchao Liu , Xiaohui Song , Xuyong Feng , Yi Sun , Hongfa Xiang . A 3D dual layer host with enhanced sodiophilicity as stable anode for high-energy sodium metal batteries. Chinese Chemical Letters, 2025, 36(6): 110007-. doi: 10.1016/j.cclet.2024.110007
10. [10]
  Guangchang Yang , Shenglong Yang , Jinlian Yu , Yishun Xie , Chunlei Tan , Feiyan Lai , Qianqian Jin , Hongqiang Wang , Xiaohui Zhang . Regulating local chemical environment in O3-type layered sodium oxides by dual-site Mg²⁺/B³⁺ substitution achieves durable and high-rate cathode. Chinese Chemical Letters, 2024, 35(9): 109722-. doi: 10.1016/j.cclet.2024.109722
11. [11]
  Hong-Tao Ji , Yu-Han Lu , Yan-Ting Liu , Yu-Lin Huang , Jiang-Feng Tian , Feng Liu , Yan-Yan Zeng , Hai-Yan Yang , Yong-Hong Zhang , Wei-Min He . Nd@C₃N₄-photoredox/chlorine dual catalyzed synthesis and evaluation of antitumor activities of 4-alkylated sulfonyl ketimines. Chinese Chemical Letters, 2025, 36(2): 110568-. doi: 10.1016/j.cclet.2024.110568
12. [12]
  Chongbei Wu , Benzhi Wang , Xuan Li , Jiaxuan Gu , Yihan Wu , Zhe Zhao , Pengfei Jia , Jizhou Jiang . Dual activation pathways based on OH-functionalized alk-Ti₃C₂ MXene/RuO_x boosting the hydrogen generation. Chinese Chemical Letters, 2025, 36(8): 111162-. doi: 10.1016/j.cclet.2025.111162
13. [13]
  Futao Yi , Ying Liu , Yao Chen , Jiahao Zhu , Quanguo He , Chun Yang , Dongge Ma , Jun Liu . Dual S-Scheme g-C₃N₄/Ag₃PO₄/g-C₃N₅ photocatalysts for removal of tetracycline pollutants through enhanced molecular oxygen activation. Chinese Chemical Letters, 2025, 36(8): 110544-. doi: 10.1016/j.cclet.2024.110544
14. [14]
  Gengchen Guo , Tianyu Zhao , Ruichang Sun , Mingzhe Song , Hongyu Liu , Sen Wang , Jingwen Li , Jingbin Zeng . Au-Fe₃O₄ dumbbell-like nanoparticles based lateral flow immunoassay for colorimetric and photothermal dual-mode detection of SARS-CoV-2 spike protein. Chinese Chemical Letters, 2024, 35(6): 109198-. doi: 10.1016/j.cclet.2023.109198
15. [15]
  Fei Yin , Erli Yang , Xue Ge , Qian Sun , Fan Mo , Guoqiu Wu , Yanfei Shen . Coupling WO₃₋_x dots-encapsulated metal-organic frameworks and template-free branched polymerization for dual signal-amplified electrochemiluminescence biosensing. Chinese Chemical Letters, 2024, 35(4): 108753-. doi: 10.1016/j.cclet.2023.108753
16. [16]
  Yuan Teng , Zichun Zhou , Jinghua Chen , Siying Huang , Hongyan Chen , Daibin Kuang . Dual atom-bridge effect promoting interfacial charge transfer in 2D/2D Cs₃Bi₂Br₉/BiOBr epitaxial heterojunction for efficient photocatalysis. Chinese Chemical Letters, 2025, 36(2): 110430-. doi: 10.1016/j.cclet.2024.110430
17. [17]
  Chenxi Shang , Boxuan Lu , Chongbei Wu , Shuqing Zhou , Luyan Shi , Tayirjan Taylor Isimjan , Xiulin Yang . Inducing electronic rearrangement through Co₃B-Mo₂B₅ catalysts: Efficient dual-function catalysis for NaBH₄ hydrolysis and 4-nitrophenol reduction. Chinese Chemical Letters, 2025, 36(9): 111152-. doi: 10.1016/j.cclet.2025.111152
18. [18]
  Xiaodong Wang , Miaomiao Zhou , Yirui Deng , Zijun Liu , Huiyou Dong , Peng Yan , Ruiping Liu . Dual functional Ti₃(PO₄)₄-coated NCM811 cathode enables highly stable sulfide-based all-solid-state lithium batteries. Chinese Chemical Letters, 2025, 36(9): 110307-. doi: 10.1016/j.cclet.2024.110307
19. [19]
  Wei Zhong , Dan Zheng , Yuanxin Ou , Aiyun Meng , Yaorong Su . Simultaneously Improving Inter-Plane Crystallization and Incorporating K Atoms in g-C₃N₄ Photocatalyst for Highly-Efficient H₂O₂ Photosynthesis. Acta Physico-Chimica Sinica, 2024, 40(11): 2406005-0. doi: 10.3866/PKU.WHXB202406005
20. [20]
  Han Han , Bi-Te Chen , Jia-Rong Ding , Jin-Ming Si , Tian-Jiao Zhou , Yi Wang , Lei Xing , Hu-Lin Jiang . A PDGFRβ-targeting nanodrill system for pancreatic fibrosis therapy. Chinese Chemical Letters, 2024, 35(10): 109583-. doi: 10.1016/j.cclet.2024.109583

Get Citation

PDF

XML

Metrics

PDF Downloads(11)
Abstract views(1062)
HTML views(183)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142